Please find enclosed herewith a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular dated July 13 2023 an update on our wholly owned subsidiary company Glenmark Pharmaceuticals INC. USA relating to settlement agreement with U.S. Department of Justice.
Recently Viewed
Clear All